Cognition Therapeutics Inc (CGTX) — Cash Flow-to-Debt Ratio
Cognition Therapeutics Inc (CGTX) has a Cash Flow-to-Debt Ratio of -0.82x as of September 2025, meaning its operating cash flow of $-5.65 Million could theoretically repay -1% of its total liabilities ($6.87 Million) in one year. See Cognition Therapeutics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cognition Therapeutics Inc Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Cognition Therapeutics Inc across 6 annual periods. Also explore CGTX year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Cognition Therapeutics Inc (2019–2024)
Year-by-year debt coverage analysis for Cognition Therapeutics Inc. For market capitalisation and broader financial context, see Cognition Therapeutics Inc (CGTX) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.48x | $-28.47 Million | $11.48 Million | ▼ -65.5% |
| 2023 | -1.50x | $-16.02 Million | $10.69 Million | ▲ +17.7% |
| 2022 | -1.82x | $-18.53 Million | $10.18 Million | ▼ -294.4% |
| 2021 | -0.46x | $-3.63 Million | $7.86 Million | ▼ -912.8% |
| 2020 | -0.05x | $-3.43 Million | $75.30 Million | ▲ +3.1% |
| 2019 | -0.05x | $-3.10 Million | $65.88 Million | — |